{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:29:13Z","timestamp":1761290953025},"reference-count":81,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T00:00:00Z","timestamp":1328745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hepato Biliary Pancreat"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Biliary tract cancers (BTCs) are a heterogeneous group of malignancies, with a historically poor prognosis as a whole. Until recently, the development of effective therapeutics was hampered by the relatively low incidence, heterogeneity in patients and tumors, and correspondingly poor clinical trial enrollments. With the publication of the landmark phase III ABC\u201002 trial demonstrating the superiority of gemcitabine and cisplatin combination chemotherapy, the landscape changed for the development of new agents. Despite this progress, there are currently no approved targeted agents for BTC. This review will focus on recent developments in targeted therapeutics, directed against several key signaling pathways in BTC, including epidermal growth factor receptor, angiogenesis, and the mitogen\u2010activated protein kinase pathway. Data from recent phase I and II trials will be discussed, along with a preview of upcoming trials involving targeted therapies.<\/jats:p>","DOI":"10.1007\/s00534-011-0496-0","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T09:50:42Z","timestamp":1328694642000},"page":"326-336","source":"Crossref","is-referenced-by-count":23,"title":["Targeted therapy for biliary tract cancers"],"prefix":"10.1002","volume":"19","author":[{"given":"Jason E.","family":"Faris","sequence":"first","affiliation":[{"name":"Harvard Medical School, Tucker Gosnell Center for Gastrointestinal Cancers Massachusetts General Hospital Cancer Center  55 Fruit Street, Yawkey 7E Boston MA 02114 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew X.","family":"Zhu","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Tucker Gosnell Center for Gastrointestinal Cancers Massachusetts General Hospital Cancer Center  55 Fruit Street, Yawkey 7E Boston MA 02114 USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,2,9]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"189","article-title":"Cholangiocarcinoma\u2014controversies and challenges","volume":"8","author":"Patel T","year":"2011","journal-title":"Nat Rev."},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-828889"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0811"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603127"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.020"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318176c4d3"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25087"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908721"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-8-170"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.4787"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.18_suppl.lba4006"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-631"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1988.tb00985.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604129"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1779"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0016-1"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1692"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00536.2002"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32410"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000217433.48870.37"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01155.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80386-4"},{"key":"e_1_2_8_24_1","first-page":"477","article-title":"Mutation of p53 and K\u2010ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma","volume":"79","author":"Kang YK","year":"1999","journal-title":"Lab Investig."},{"key":"e_1_2_8_25_1","first-page":"604","article-title":"Analysis of microsatellite instability, K\u2010ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma","volume":"49","author":"Isa T","year":"2002","journal-title":"HepatoGastroenterology"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9098(200003)73:3<158::AID-JSO9>3.0.CO;2-N"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.7.1679"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.2940060408"},{"key":"e_1_2_8_29_1","first-page":"3156","article-title":"K\u2010ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population\u2010based study in China","volume":"8","author":"Rashid A","year":"2002","journal-title":"Clin Cancer Res."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-60"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.706"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.3579"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.18_suppl.lba4032"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.4075"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-190"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70247-3"},{"key":"e_1_2_8_37_1","article-title":"A multi\u2010center, randomized phase II trial of gemcitabine and oxaliplatin (GEMOX) alone or in combination with biweekly cetuximab in the first\u2010line treatment of advanced biliary cancer: Interim analysis of the BINGO trial","volume":"27","author":"Malka D FL","year":"2009","journal-title":"J Clin Oncol."},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000111117"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000264613"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.4101"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805019"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.5091"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00077-X"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3214"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23773"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0927-7"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61121-X"},{"key":"e_1_2_8_48_1","first-page":"2257","article-title":"Vascular endothelial growth factor expression is an independent negative predictor in extrahepatic biliary tract carcinomas","volume":"19","author":"Hida Y","year":"1999","journal-title":"Anticancer Res."},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.coc.0000204402.29830.08"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2003.09.013"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20443"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70333-X"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605458"},{"key":"e_1_2_8_54_1","unstructured":"El\u2010KhoueiryAB RankinCJ Ben\u2010JosefE LenzHJ GoldPJ HamiltonRD et al.SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma.Invest New Drugs[Epub ahead of print]."},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.4077"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.e14653"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604988"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0196"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.8135"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808268"},{"key":"e_1_2_8_61_1","first-page":"957","article-title":"A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K\u2010ras mutation: analysis in a novel orthotopic inoculation model","volume":"23","author":"Horiuchi H","year":"2003","journal-title":"Int J Oncol."},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.9473"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.9316"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2009.11.002"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63645-0"},{"key":"e_1_2_8_66_1","first-page":"6971","article-title":"Constitutive expression of ErbB\u20102 in gallbladder epithelium results in development of adenocarcinoma","volume":"61","author":"Kiguchi K","year":"2001","journal-title":"Cancer Res."},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27282"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20540"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2010.06.009"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-007-2055-7"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001148"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2001752"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3181f09179"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800204"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-004-1046-9"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.121.1.145"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3012"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2002.00353.x"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.199"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(98)90229-5"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1141478"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0707270105"}],"container-title":["Journal of Hepato-Biliary-Pancreatic Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1007%2Fs00534-011-0496-0","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s00534-011-0496-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:10:30Z","timestamp":1694632230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s00534-011-0496-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,9]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1007\/s00534-011-0496-0"],"URL":"https:\/\/doi.org\/10.1007\/s00534-011-0496-0","archive":["Portico"],"relation":{},"ISSN":["1868-6974","1868-6982"],"issn-type":[{"value":"1868-6974","type":"print"},{"value":"1868-6982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,9]]}}}